| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Departments of Biochemistry [E. M. S., A. H. M.], Pathology [D. L. D.], and Chemistry and the Emory Mass Spectrometry Center [A. R., J. A.], and Division of Animal Resources [D. L. D., S. K. W.], Emory University, Atlanta, Georgia 30322
Sphingolipids are hydrolyzed in the gastrointestinal tract to ceramide, sphingosine, and other metabolites that can modulate cell growth, differentiation, and apoptosis. To characterize the effects of dietary sphingolipids on colon carcinogenesis, female CF1 mice were administered 1,2-dimethylhydrazine and then fed an essentially sphingolipid-free diet supplemented with 0 to 0.1% (w/w) sphingomyelin (SM) purified from milk. As was found in a previous pilot study (D. L. Dillehay et al., J. Nutr., 124: 615620, 1994), SM (@ 0.1%) reduced the number of aberrant colonic crypt foci (by 70%, P < 0.001) and aberrant crypts per focus (by 30%, P < 0.003), which are early indicators of colon carcinogenesis. In longer term studies, SM had no effect on colon tumor incidence or multiplicity; however, up to 31% of the tumors of mice fed SM were adenomas, whereas all of the tumors of mice fed the diet without SM were adenocarcinomas. These findings demonstrate that milk SM suppresses the appearance of more advanced, malignant tumors as well as early markers of colon carcinogenesis. Although the sphingolipid content of foods has not been widely studied, several foods (e.g., milk and soybeans) contain the sphingolipid levels used in these investigations; therefore, this class of compounds could be significant contributors to the cancer preventive effects of some foods.
1 Supported by funds from the National Dairy Board administered in cooperation with the National Dairy Council and National Cancer Institute Grant CA61820.
2 To whom requests for reprints should be addressed, at Department of Biochemistry, 4113 Rollins Research Center, Emory University, Atlanta, GA 30322. Phone: (404) 727-5978; Fax: (404) 727-3954.
Received 7/ 2/96. Accepted 9/ 3/96.
This article has been cited by other articles:
![]() |
R. Rombaut and K. Dewettinck Thermocalcic Aggregation of Milk Fat Globule Membrane Fragments from Acid Buttermilk Cheese Whey J Dairy Sci, June 1, 2007; 90(6): 2665 - 2674. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Rombaut, V. Dejonckheere, and K. Dewettinck Filtration of Milk Fat Globule Membrane Fragments from Acid Buttermilk Cheese Whey J Dairy Sci, April 1, 2007; 90(4): 1662 - 1673. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. H. Ahn, C.-C. Chang, and J. J. Schroeder Evaluation of sphinganine and sphingosine as human breast cancer chemotherapeutic and chemopreventive agents. Experimental Biology and Medicine, November 1, 2006; 231(10): 1664 - 1672. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Moussavi, K. Assi, A. Gomez-Munoz, and B. Salh Curcumin mediates ceramide generation via the de novo pathway in colon cancer cells Carcinogenesis, August 1, 2006; 27(8): 1636 - 1644. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kono, J. L. Dreier, J. M. Ellis, M. L. Allende, D. N. Kalkofen, K. M. Sanders, J. Bielawski, A. Bielawska, Y. A. Hannun, and R. L. Proia Neutral Ceramidase Encoded by the Asah2 Gene Is Essential for the Intestinal Degradation of Sphingolipids J. Biol. Chem., March 17, 2006; 281(11): 7324 - 7331. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Sodini, P. Morin, A. Olabi, and R. Jimenez-Flores Compositional and Functional Properties of Buttermilk: A Comparison Between Sweet, Sour, and Whey Buttermilk J Dairy Sci, February 1, 2006; 89(2): 525 - 536. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C Larsson, L. Bergkvist, and A. Wolk High-fat dairy food and conjugated linoleic acid intakes in relation to colorectal cancer incidence in the Swedish Mammography Cohort Am. J. Clinical Nutrition, October 1, 2005; 82(4): 894 - 900. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Di Marzio, A. Di Leo, B. Cinque, D. Fanini, A. Agnifili, P. Berloco, M. Linsalata, D. Lorusso, M. Barone, C. De Simone, et al. Detection of Alkaline Sphingomyelinase Activity in Human Stool: Proposed Role as a New Diagnostic and Prognostic Marker of Colorectal Cancer Cancer Epidemiol. Biomarkers Prev., April 1, 2005; 14(4): 856 - 862. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Castillo and D. Teegarden Sphingosine-1-Phosphate Inhibition of Apoptosis Requires Mitogen-Activated Protein Kinase Phosphatase-1 in Mouse Fibroblast C3H10T1/2 Cells J. Nutr., November 1, 2003; 133(11): 3343 - 3349. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Sugawara, M. Kinoshita, M. Ohnishi, J. Nagata, and M. Saito Digestion of Maize Sphingolipids in Rats and Uptake of Sphingadienine by Caco-2 Cells J. Nutr., September 1, 2003; 133(9): 2777 - 2782. [Abstract] [Full Text] [PDF] |
||||
![]() |
R.-D. Duan, Y. Cheng, G. Hansen, E. Hertervig, J.-J. Liu, I. Syk, H. Sjostrom, and A. Nilsson Purification, localization, and expression of human intestinal alkaline sphingomyelinase J. Lipid Res., June 1, 2003; 44(6): 1241 - 1250. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Silins, M. Nordstrand, J. Hogberg, and U. Stenius Sphingolipids suppress preneoplastic rat hepatocytes in vitro and in vivo Carcinogenesis, June 1, 2003; 24(6): 1077 - 1083. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Chung, D. Wu, S. N. Han, R. Gay, B. Goldin, R. E. Bronson, J. B. Mason, D. E. Smith, and S. N. Meydani Vitamin E Supplementation Does Not Alter Azoxymethane-Induced Colonic Aberrant Crypt Foci Formation in Young or Old Mice J. Nutr., February 1, 2003; 133(2): 528 - 532. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. H. Ahn and J. J. Schroeder Sphingoid Bases and Ceramide Induce Apoptosis in HT-29 and HCT-116 Human Colon Cancer Cells Experimental Biology and Medicine, May 1, 2002; 227(5): 345 - 353. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Cheng, A. Nilsson, E. Tomquist, and R.-D. Duan Purification, characterization, and expression of rat intestinal alkaline sphingomyelinase J. Lipid Res., February 1, 2002; 43(2): 316 - 324. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Schmelz, M. C. Sullards, D. L. Dillehay, and A. H. Merrill Jr. Colonic Cell Proliferation and Aberrant Crypt Foci Formation Are Inhibited by Dairy Glycosphingolipids in 1,2-Dimethylhydrazine-Treated CF1 Mice J. Nutr., March 1, 2000; 130(3): 522 - 527. [Abstract] [Full Text] |
||||
![]() |
E. M. Schmelz, A. S. Bushnev, D. L. Dillehay, M. C. Sullards, D. C. Liotta, and A. H. Merrill Jr. Ceramide-{{beta}}-D-Glucuronide: Synthesis, Digestion, and Suppression of Early Markers of Colon Carcinogenesis Cancer Res., November 1, 1999; 59(22): 5768 - 5772. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Vesper, E.-M. Schmelz, M. N. Nikolova-Karakashian, D. L. Dillehay, D. V. Lynch, and A. H. Merrill Jr. Sphingolipids in Food and the Emerging Importance of Sphingolipids to Nutrition J. Nutr., July 1, 1999; 129(7): 1239 - 1250. [Abstract] [Full Text] |
||||
![]() |
P. R. Holt, E. O. Atillasoy, J. Gilman, J. Guss, S. F. Moss, H. Newmark, K. Fan, K. Yang, and M. Lipkin Modulation of Abnormal Colonic Epithelial Cell Proliferation and Differentiation by Low-Fat Dairy Foods: A Randomized Controlled Trial JAMA, September 23, 1998; 280(12): 1074 - 1079. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |